Journal
DEVELOPMENTAL DYNAMICS
Volume 231, Issue 1, Pages 179-189Publisher
WILEY-LISS
DOI: 10.1002/dvdy.20123
Keywords
hyperglycemia; TGF beta; fibronectin; embryonic heart; protein; mRNA
Categories
Funding
- NHLBI NIH HHS [HL60752] Funding Source: Medline
Ask authors/readers for more resources
Cardiovascular defects are common in diabetic offspring, but their etiology and pathogenesis are poorly understood. Extracellular matrix accumulates in adult tissues in response to hyperglycemia, and transforming growth factor-beta1 (TGFbeta1) likely mediates this effect. The objective of this study was to characterize TGFbeta expression in the organogenesis-stage mouse heart and to evaluate TGFbeta and fibronectin expression in embryonic mouse heart exposed to hyperglycemia. Prominent TGFbeta1, and minimal TGFbeta2 or TGFbeta3, protein expression was demonstrated in embryonic day (E) 9.5-E13.5 hearts. Hyperglycemia for 24 hr produced significantly increased fibronectin, slightly increased TGFbeta1, and unchanged TGFbeta2 or TGFbeta3, by immunohistochemistry. Increased TGFbeta1 was demonstrated by enzyme-linked immunosorbent assay in embryonic fluid and isolated hearts after hyperglycemia for 24 hr, but not 48 hr. Hyperglycemia increased fibronectin protein and mRNA expression in embryonic hearts after 24 hr, and pericardial injection of TGFbeta1 also increased fibronectin mRNA in the embryonic heart. It is proposed that TGFbeta1 and fibronectin may play a role in diabetes-induced cardiac dysmorphogenesis. (C) 2004 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available